Openbookopenbook
Equity
MDLYF(MDLYF)
USD --+0.00%
Reward72High
Risk39Moderate
📊75%Data
Thin 3% profit margin · Revenue growing 21% YoY
MDLYF
+0.0 · +0.00%
USD · PINK
MDLYF | Healthcare
Growth Machine
Market Cap:497.34M
ℹ️
Reward Rating
72
High
Top 25% (model universe)
75% data coverage
ℹ️
Risk Rating
39
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on MDLYF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is MDLYF?

operates platforms for recruitment and medical businesses in Japan and the United States.

MDLYF · Verdict

Strong reward · moderate risk

MDLYF scores well on growth and cash flow with no major weaknesses flagged in the model.

Based on 88% data coverage

MDLYF · Verdict

What’s working & what to watch

Strengths 4

  • Growth96/100

    Rev +39.2% CAGR · earnings +70.7%

  • Cash flow71/100

    7% free-cash-flow margin

  • Profitability65/100

    10% net margin · 6% ROE

  • Volatility65/100

    Above average

No major weaknesses flagged.

Model-based scoring. For information only — not financial advice.

What is MDLYF?

operates platforms for recruitment and medical businesses in Japan and the United States. It operates through three segments: Human Resources Platform Business, Medical Platform Business, and New Development Services. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 497.34M, and a P/E ratio of 80.4x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: High (72)

The scoring profile indicates a strong reward potential, driven primarily by growth and profitability. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap497.34M
P/E Ratio80.4495
Dividend YieldN/A
52 Week High22.84
52 Week Low14.24
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding31M
No. of Employees1,487
IndustryHealth Information Services
ExchangePINK
Beta0.796
CurrencyUSD · Reports in JPY
Websitewww.medley.jp
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.